MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
LYB HOLD REF $55 PW TARGET $58 (+7% vs spot · 12m PWEV) +5% Single-name research · 8 July 2026
Equity ResearchMaterials · Specialty Chemicals
LYB

LyondellBasell Industries NV (LYB)

HOLD. 12-month probability-weighted target $58 (+5% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

Verdict
HOLD
Triangulated fair value $42 (-24% vs spot · triangulated FV)
Reference
$55
Close · 8 July 2026
PW Target
$58 (+7% vs spot · 12m PWEV) +5%
Probability-weighted
Horizon
12 mo
MCH Advisory
$42 (-24% vs spot · triangulated FV)
Fair value
$58 (+7% vs spot · 12m PWEV)
Scenario PWEV
6.9x
Forward P/E
$18B
Market cap
$40–$83
52-week range
Contents

Rating: HOLD

HOLD (5-tier) · balance-sheet repair · conviction: low

Metric Value
Current Price $55
Triangulated Fair Value $42 (-24% vs spot · triangulated FV)
12-mo Scenario PWEV $58 (+7% vs spot · 12m PWEV)
Forward P/E 6.9x
Market Cap $18B
52-Week Range $40–$83

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

Rating HOLD · HOLD (5-tier)
Classification · conviction balance-sheet repair · low
Triangulated fair value $42 (-24% vs spot · triangulated FV)
12-mo scenario PWEV $58 (+7% vs spot · 12m PWEV)
Next catalyst 2026-08-01 — Ethylene/PE spread inflection vs new Asian/Middle-East capacity startups
Primary thesis-break Integrated ethylene / polyethylene chain margin (US Gulf, cents/lb) below trough-consistent level for 2 consecutive quarters (2 consecutive prints)

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

  • Probability-weighted scenario value implies +7% vs spot
  • Monte Carlo median implies -9% vs spot
  • DCF fair value implies -52% vs spot — but this is terminal-value sensitive (exit-multiple $26 vs Gordon $71, 172% apart), so it carries less weight
  • Bear case (Structural — Petrochem Overcapacity / Demand Peak) downside is -73% vs spot
  • Net: reward/risk of 0.3× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $52.65 on a 6.6x forward multiple and an 8.5% dividend yield, the market prices LyondellBasell as a deep cyclical stuck near trough, discounting little recovery in petrochemical spreads. The engine concurs directionally: the probability-weighted target of $55.51 sits only 5% above spot, and the cross-sectional peers (SHW, ECL, PPG at 15-34x) confirm this is a commodity, not a compounder. The Base case rests on mid-cycle spreads returning group op-margin toward 11.4% on roughly flat volumes, yielding EPS near $8.6 and a $57.7 target at a 7x multiple. Our view differs from the tape only modestly, because structural overcapacity carries a 24% weight and the highest-probability bear (Base plus Downturn glut) dominates the distribution. The rating is HOLD: the yield pays while spreads stay depressed, but the DCF anchor of $27.6 warns the payout is not fully covered by mid-cycle free cash flow. The single most damaging risk is that new Middle East and Chinese ethylene capacity keeps operating rates and spreads below mid-cycle for years, not quarters.

The dashboard below is the whole argument on one page: spot ($55) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the $55 spot from $26 to <img src=
Integrated dashboard. The five valuation anchors bracket the $55 spot from $26 to $180 — fairly valued — spot brackets the blend.

Anti-Thesis (The Real Bear Case)

The steelman bear is structural, not cyclical. A wave of new integrated ethylene and polyolefin capacity from the Middle East and China arrives into flat-to-declining developed-market demand, so global operating rates never recover to the levels that mid-cycle economics assume. Spreads settle at a permanently lower plateau, group op-margin sits closer to 8% than 11.4%, and FY2025 operating cash flow of $2.26B fails to cover the $1.76B dividend plus $1.9B capex. Management defends the 8.5% yield with balance-sheet capacity against $11.6B of net debt, leverage drifts above 3.5x, and the equity de-rates toward the Structural target below the $39.52 52-week low. In that path the multiple and earnings compress together.

Key Debate

Gross Margin explains 51% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.56 vs analyst floor -0.01 → delta +0.57 (n=29 mgmt / 10 Q&A; 83th pctile across the S&P book, z +1.1).

Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).

Quarter Mgmt Analyst Delta
2026Q1 +0.56 -0.01 +0.57
2025Q4 +0.31 +0.14 +0.17
2025Q3 +0.52 +0.00 +0.52
2025Q2 +0.44 +0.15 +0.29

News (last 365d, 680 articles): avg ticker sentiment -0.08 (bullish 7% / bearish 33%)

Scenario Analysis

The tree runs from a structural 'Structural — Petrochem Overcapacity / Demand Peak' downside ($15) to a 'Spike — Supply Dislocation' bull case ($137); the probability-weighted blend (PWEV $58) is +7% versus spot.

Scenario Probability Target Return vs spot
Structural — Petrochem Overcapacity / Demand Peak 24% $15 -73%
Downturn — Trough Margins 18% $31 -44%
Base — Mid-Cycle Spreads 32% $60 +10%
Upcycle — Tight Spreads 18% $106 +94%
Spike — Supply Dislocation 8% $137 +151%
Probability-Weighted (PWEV) $58 +7%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — Petrochem Overcapacity / Demand Peak (24%, $15). Structural impairment — capacity glut / demand peak: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 14.57; probability: 0.24.
  • Downturn — Trough Margins (18%, $31). Cyclical downturn — petrochemical spreads (ethylene/PE/PP) + feedstock + global demand weakens for 1–2 years before normalising. Drivers — implied_target: 31.48; probability: 0.18.
  • Base — Mid-Cycle Spreads (32%, $60). Mid-cycle — normalised petrochemical spreads (ethylene/PE/PP) + feedstock + global demand; disciplined capital allocation; steady returns. Drivers — implied_target: 57.7; probability: 0.32.
  • Upcycle — Tight Spreads (18%, $106). Upside — supply dislocation / tight spreads lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 98.37; probability: 0.18.
  • Spike — Supply Dislocation (8%, $137). Upside tail — sustained tight conditions or a structural re-rate on supply dislocation / tight spreads. Drivers — implied_target: 127.22; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the $55 spot; PWEV $58 (+7% vs spot · 12m). the payoff shows modest positive expectancy with material downside mass (range <img src=
Five-scenario tree. Probability-weighted targets around the $55 spot; PWEV $58 (+7% vs spot · 12m). the payoff shows modest positive expectancy with material downside mass (range $15–$137)

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $50 -9%
Peer P/E re-rate multiple $180 +230%
Peer EV/Revenue re-rate multiple $256 +369%
Scenario PWEV multiple $58 +7%
DCF (5-year + terminal) cash flow + terminal × $26 -52%
Triangulated (weighted) $42 -24%

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.

Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $50 + scenario PWEV $58, ≈ spot); the weighted blend $42 (-24%) sits below it because the cash-flow DCF ($26) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $50 and 45% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (51% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

Monte Carlo distribution. Median $50; P(price > current) 45%. P10–P90: <img src=
Monte Carlo distribution. Median $50; P(price > current) 45%. P10–P90: $19–$106.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 9.5%, 6x terminal FCF multiple → $26. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Independent DCF. WACC 9.5%, 6x terminal → $26.
Independent DCF. WACC 9.5%, 6x terminal → $26.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 22.755000000000003x) implies $180. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 22.755000000000003x → <img src=
Cross-sectional peer benchmarking. Peer-median fwd P/E 22.755000000000003x → $180; EV/Rev re-rate → $256.

Across all anchors the spread is 393% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Commodity Chemicals / Petrochemicals $29.7B 100% 2% 11% $3.4B 7x 7% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver petrochemical spreads (ethylene/PE/PP) + feedstock + global demand
net_debt_or_cash_b -11.61

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.07
div_yield 0.0855

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside capacity glut / demand peak
upside supply dislocation / tight spreads

Industry Context — Materials — Commodity

This name sits in the Materials — Commodity as a commodity_chem. petrochemical spreads (ethylene/PE/PP) + feedstock + global demand Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: DOW (commodity_chem) · LYB (commodity_chem) · ALB (lithium) · CF (fertilizer) · MOS (fertilizer)

Shared state Capex path House view This name implies
Commodity Glut — Oversupply / Demand Reset 42% 42%
Mid-Cycle — Normalised Prices 32% 32%
Tight Market — Upcycle / Spike 26% 26%

Mapping note: name-level 'Structural — Petrochem Overcapacity / Demand Peak' (24%) + 'Downturn — Trough Margins' (18%) map to cluster Commodity Glut — Oversupply / Demand Reset (42%); name-level 'Upcycle — Tight Spreads' (18%) + 'Spike — Supply Dislocation' (8%) map to cluster Tight Market — Upcycle / Spike (26%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Commodity Glut — Oversupply / Demand Reset () — this name implies 42% vs the cluster house view of 42% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The commodity cycle is the shared macro driver. Driver — commodity-chemical / nutrient / lithium price cycle + feedstock costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

Year Revenue Op income − Capex + D&A FCF PV(FCF)
FY+1 $30B $3B $2B $2B $2B $2B
FY+2 $31B $3B $2B $2B $3B $2B
FY+3 $31B $4B $2B $2B $3B $2B
FY+4 $31B $4B $2B $2B $3B $2B
FY+5 $32B $4B $2B $2B $3B $2B
Terminal $3B × 6x $10B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 7% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 9.5% · Σ PV(FCF) $10B + PV(terminal) $10B = EV $20B; + net cash → equity $9B ÷ diluted shares 0.33B = $26/share (exit-multiple terminal).

  • Gordon (perpetuity-growth) terminal at 2.5% → $71/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
  • Incremental ROIC on the forecast capex ≈ 3% vs WACC 10% → below WACC — the incremental build is value-dilutive.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
SHW 4.061x 28.82x 5% 14%
ECL 5.34x 33.56x 5% 17%
PPG 2.071x 15.46x 5% 14%
IFF 2.321x 16.69x 5% 10%
Median 3.191x 22.755000000000003x

Peer-median fwd P/E → $180; EV/Rev → $256.

Weighted fair-value math

Anchor Value Weight Contribution
DCF $26 47% $12
Scenario PWEV $58 33% $19
Monte Carlo median $50 20% $10
Triangulated 100% $42

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 4.2x 5.1x 6.0x 6.9x 7.8x
8% $21 $26 $31 $36 $41
8% $19 $24 $29 $34 $38
10% $17 $22 $26 $31 $36
10% $15 $20 $24 $29 $33
12% $13 $18 $22 $26 $31

DCF/share — revenue CAGR Δ × op-margin Δ

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $4 $12 $19 $27 $34
-1.5pp $7 $15 $23 $31 $39
+0.0pp $9 $18 $26 $35 $43
+1.5pp $12 $21 $30 $39 $48
+3.0pp $15 $25 $34 $44 $53

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Op margin ±3pp $9 $43 $34
Revenue CAGR ±3pp $19 $34 $15
Capex intensity ±15% $19 $34 $14
Terminal × ±15% $22 $31 $9
WACC ±1pp $24 $29 $4

Company lever — SoP/share vs Commodity Chemicals / Petrochemicals multiple (AI re-rating) (base 7x)

Multiple 4.9x 6.0x 7.0x 8.0x 9.1x
SoP/share $415 $516 $608 $700 $801

Consensus & Market Expectations

Reference Value
Street target (mean) $73 (+33% vs spot · street)
House target $56 (-23.8% vs street)
Sell-side coverage 18 analysts (SB 2 / B 4 / H 9 / S 2 / SS 1; net score 0.11)
Consensus FY EPS $6.88; house above (+15.3%)
Consensus FY revenue $33.2B; house below (-8.8%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Metric Value
Net debt $12.5B — highly levered
Net debt / EBITDA 5.63x
Interest coverage (EBIT / interest) -0.4x
Current ratio 1.77x
Lease obligations $1.7B
Cash & ST investments $3.4B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $0.4B
Buybacks / dividends $0.2B / $1.8B
Total shareholder yield 11.1%
Payout as % of FCF 511.7%
Reinvestment (capex / OCF) 83.0%
SBC as % of FCF 23.7%
Allocation stance returning more than FCF (balance-sheet funded)

Free-Cash-Flow Quality

Metric Value
FCF margin 1.3%
FCF conversion (FCF / net income) -52.0%
FCF yield 2.2%
Capex intensity (capex / revenue) 6.3%
FCF − SBC (diagnostic) $0.3B
Capex split (maint / growth) 60% / 40% — Capex ~7% of revenue; turnaround/maintenance-heavy for an asset-intensive cracker fleet, with growth spend on select debottlenecking and circular/recycling projects.

Accounting quality: SBC 0.3% of revenue; cash conversion (OCF/NI) -306% — cash-backed.

Catalyst Calendar

  • 2026-08-01 (~24d) — Ethylene/PE spread inflection vs new Asian/Middle-East capacity startups (authored)
  • 2026-08-07 (~30d) — Quarterly earnings — est. EPS $2.94 (AV EARNINGS_CALENDAR)
  • 2026-10-30 (~114d) — European asset-rationalization / portfolio-review decision (authored)
  • 2027-02-15 (~222d) — Dividend-sustainability review at FY results (authored)

Forecast Track Record

  • EPS surprise: beat 37.5% of the last 8 quarters; average surprise -69.1%.

Competitive Moat

Narrow moat. LyondellBasell's moat is cost-advantaged US/Gulf-Coast feedstock (ethane) and scale plus proprietary licensing (Oleflex/polyolefin technology), which supports only a mid-single-digit-to-high-single-digit terminal multiple appropriate for a deep cyclical. FALSIFIABLE: if global ethylene/PE overcapacity keeps spreads at trough through the next cycle, the cost advantage is being competed away and even a ~7x multiple is too generous - fair value sits below the current dividend-supported floor.

Moat sources:

  • US Gulf-Coast ethane feedstock cost advantage vs naphtha crackers
  • Scale in olefins/polyolefins and integrated cracker footprint
  • Technology licensing (Oleflex, polyolefin process IP) - annuity-like royalty
  • NO pricing power - commodity chemicals are spread-takers, not price-setters
Issue Probability Valuation sensitivity Horizon
Environmental/carbon regulation (EU ETS, US emissions rules) and plastics/circular-economy mandates raising compliance cost medium (~45%) medium - compliance capex and asset-stranding risk ~4-6% of FV 12-24m
Trade/tariff and feedstock-export policy affecting spread differentials medium (~35%) low-medium - spread impact ~2-4% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — Petrochem Overcapacity / Demand Peak Sustained global ethylene/PE overcapacity from Asian/ME startups meets peaking demand, holding spreads at trough Spreads never recover through the cycle and the dividend gets cut - fair value below the current floor
Downturn — Trough Margins Cyclical trough with weak demand and negative operating leverage on high fixed costs Trough deepens and free cash flow can't cover the ~8.5% dividend
Base — Mid-Cycle Spreads Spreads normalize toward mid-cycle as demand recovers and capacity additions digest Overcapacity delays the mid-cycle recovery, keeping the 7x multiple capped
Upcycle — Tight Spreads Demand recovery outpaces capacity, tightening ethylene/PE spreads Tight spreads pull forward new capacity that ends the upcycle early
Spike — Supply Dislocation Supply dislocation (outages, feedstock shock) spikes spreads sharply above mid-cycle A spike is transient and mean-reverts fast; capacity responds and demand destructs

What the Market Is Pricing In

At the current price, the market pays 7.9× forward EPS, vs the house DCF terminal 6.0×, and a peer median 22.755000000000003×. The house DCF sits 52% below spot, so the market is pricing in more than the house case — roughly 2.7pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily margin-driven.

Metric Consensus House Importance
Revenue 33.2 30.3 High
EPS 6.9 7.9 Medium
Target price 72.8 55.5 Medium

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
SHW 28.82× 5% 14% broad 25%
ECL 33.56× 5% 17% broad 25%
PPG 15.46× 5% 14% broad 25%
IFF 16.69× 5% 10% broad 25%

Quality-weighted forward P/E: 23.6× (simple median 22.755000000000003×). Direct peers count 100%, segment 50%, broad 25%.

Valuation-anchor screen: DCF (exit) (low-confidence cross-check (>50% below median)); Peer (fwd P/E) (excluded (>3× or <0.3× spot)). Anchor median 58.4. Extreme/excluded anchors carry no headline weight.

Historical-range cross-check: 52-week range $40–$83, centre $57 (+5% vs spot); spot sits at the 35th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $42 (-24% vs spot · triangulated FV)
Downside to bear case (Structural — Petrochem Overcapacity / Demand Peak) $15 (-73% vs spot · bear scenario)
Reward/risk ratio 0.3×
Margin of safety (FV vs spot) -31%
P(price > spot) — Monte Carlo 45%

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Spike — Supply Dislocation): $137.

Assumption Register

Assumption Value Used in Source
WACC 9.5% DCF discount rate estimate (CAPM)
Terminal multiple DCF exit value estimate (peer-anchored)
Terminal growth 2.5% DCF Gordon terminal estimate
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (34.0); Revenue CAGR ±3pp (15.0); Capex intensity ±15% (14.0); Terminal × ±15% (9.0); WACC ±1pp (4.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $29.7B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $30.3B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $6.8792 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.325B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $12.513B reported fact Balance sheet via AV High EV, DCF equity bridge
WACC 9.5% house estimate CAPM (beta/rf) Medium DCF discount rate
Terminal multiple house estimate Peer/historical range Medium DCF exit value
Terminal growth 2.5% house estimate Long-run GDP+ Medium DCF Gordon terminal

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-07-08 Price, market cap, EV, 52-week range, forward P/E Alpha Vantage 2026-06-26
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-07-08 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-07-08 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-07-08 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-07-08 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-07-08 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-07-08 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-07-08 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 10%, terminal multiple 6×, FY+5 revenue $32B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Integrated ethylene / polyethylene chain margin (US Gulf, cents/lb) below trough-consistent level for 2 consecutive quarters (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). Spread compression toward trough is the direct transmission into the Downturn and Structural scenarios; sustained sub-mid-cycle spreads invalidate the Base op-margin of 11.4%.
  • Group EBITDA margin below 9.8% (midpoint of Base 11.4% and Downturn 8.2% op-margin proxy) (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). A sustained margin print between Base and Downturn confirms the cycle is rolling toward the higher-probability bear case rather than normalising.
  • Operating cash flow coverage of dividend + capex below 1.0x (OCF < dividend $1.76B + capex ~$1.9B) (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). FY2025 OCF of $2.26B already sat near dividend-plus-capex; a sustained shortfall pressures the 8.5% yield and forces balance-sheet funding of the payout given net debt of $11.6B.
  • Net debt / EBITDA above 3.5x (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). Rising leverage in a trough constrains capital returns and moves the equity toward the Structural target below the 52-week low of $39.52.
  • Global operating-rate for ethylene / polyolefins below the level consistent with structural overcapacity absorption stalling (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). New Middle East and Chinese capacity keeps operating rates depressed; a stall confirms the Structural demand-peak thesis rather than a normal cyclical trough.

Fact / Inference / Speculation

  • FACT: Spot $55; 52-week range $40–$83; engine rating HOLD; base-case target $56 (+2%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
  • INFERENCE: Triangulated FV $42 (-24% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Recommendation: HOLD

Balanced: triangulated fair value $58 (+6% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.
Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.